Susan Thornton

Susan has over 20 years of domestic and international drug development experience encompassing all aspects of global Regulatory Affairs and Quality Assurance. Before joining Galectin, Susan served as Vice President, Regulatory Affairs and Quality Assurance, at Xeris BioPharma (formerly Strongbridge Biopharma), where she served as a key contributor for the development through approval and launch of the Recorlev® as well as the acquisition and launch of other commercial products. Prior, she held roles of increasing responsibility spanning early-and late-stage development through commercialization of eight NDAs at previous roles including those with Antares Pharma, Aptalis Pharma (formerly Eurand Pharmaceuticals), Barrier Therapeutics, and Teva Pharmaceuticals USA.

Susan received her B.S in Chemistry from Rider University and her M.S. in Quality Assurance/ Regulatory Affairs from Temple University School of Pharmacy.